In recent studies, the void of evaluation and in-depth understanding of unknown clinically
relevant potential molecular biomarkers involved in colorectal cancer (CRC) from the …

Background A deep understanding of potential molecular biomarkers and therapeutic
targets related to the progression of colorectal cancer (CRC) from early stages to metastasis …

Background Colitis-associated colon cancer (CAC) patients have a younger age of onset,
more multiple lesions and invasive tumors than sporadic colon cancer patients. Early …

Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disorder of the colon,
characterized by continuous mucosal inflammation. Recently, some studies have …

Colorectal cancer (CRC) is one of the most malignant cancers with high morbidity and
mortality. MicroRNAs (miRNAs) are small non-coding RNAs that affect biological processes …

Colorectal cancer (CRC) remains a global disease burden and a leading cause of cancer
related deaths worldwide. The identification of aberrantly expressed messenger RNA …

Colon cancer (CC) is the fourth deadliest cancer in the world. New insights into
prognostication might be helpful to define the optimal adjuvant treatments for patients in …

Introduction Colorectal cancer (CRC) is the fourth most common cause of cancer-related
mortality worldwide. The tumor, node, metastasis (TNM) stage remains the standard for CRC …

Background Ulcerative colitis (UC) refers to an intractable intestinal inflammatory disease. Its
increasing incidence rate imposes a huge burden on patients and society. The UC etiology …

Introduction: Ulcerative colitis (UC) is a chronic inflammatory disease of the intestine whose
cause and underlying mechanisms are not fully understood. The aim of this study was to use …